DE LUCA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.550
EU - Europa 3.498
AS - Asia 3.174
SA - Sud America 1.055
Continente sconosciuto - Info sul continente non disponibili 602
AF - Africa 92
OC - Oceania 4
Totale 13.975
Nazione #
US - Stati Uniti d'America 5.214
RU - Federazione Russa 2.266
SG - Singapore 1.311
BR - Brasile 864
CN - Cina 626
IT - Italia 616
HK - Hong Kong 528
BD - Bangladesh 188
VN - Vietnam 156
CA - Canada 137
FR - Francia 130
GB - Regno Unito 102
DE - Germania 97
IN - India 78
MX - Messico 73
IE - Irlanda 66
AR - Argentina 58
NL - Olanda 39
AT - Austria 37
ZA - Sudafrica 35
EC - Ecuador 34
IQ - Iraq 33
CO - Colombia 31
TR - Turchia 30
PK - Pakistan 26
CR - Costa Rica 25
ID - Indonesia 25
JM - Giamaica 25
FI - Finlandia 23
SE - Svezia 21
VE - Venezuela 20
CL - Cile 19
MY - Malesia 19
ES - Italia 18
PH - Filippine 18
SA - Arabia Saudita 18
UA - Ucraina 18
UZ - Uzbekistan 18
HN - Honduras 16
JP - Giappone 16
PL - Polonia 16
MA - Marocco 12
PE - Perù 12
IL - Israele 11
TT - Trinidad e Tobago 11
JO - Giordania 10
TH - Thailandia 10
NI - Nicaragua 9
SV - El Salvador 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CI - Costa d'Avorio 8
EE - Estonia 8
PY - Paraguay 8
KE - Kenya 7
TN - Tunisia 7
EG - Egitto 6
DO - Repubblica Dominicana 5
GT - Guatemala 5
LB - Libano 5
LT - Lituania 5
UY - Uruguay 5
AU - Australia 4
BG - Bulgaria 4
CH - Svizzera 4
CW - ???statistics.table.value.countryCode.CW??? 4
GP - Guadalupe 4
NP - Nepal 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
HT - Haiti 3
KG - Kirghizistan 3
QA - Qatar 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BE - Belgio 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
GD - Grenada 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
LV - Lettonia 2
MT - Malta 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
Totale 13.354
Città #
Ashburn 907
Moscow 736
Council Bluffs 597
Singapore 549
San Jose 534
Hong Kong 525
Dallas 349
Los Angeles 135
Beijing 133
Phoenix 118
Santa Clara 114
The Dalles 108
Lauterbourg 81
New York 80
Columbus 78
Dublin 65
Messina 62
North Bergen 59
Buffalo 56
Ho Chi Minh City 55
São Paulo 53
Catania 41
Hanoi 40
Mexico City 39
Redondo Beach 39
Rome 38
Milan 37
Rio de Janeiro 34
Frankfurt am Main 33
Atlanta 32
Orem 31
Paternò 30
Boardman 28
Brooklyn 28
Chicago 28
Belo Horizonte 27
Houston 27
Munich 27
Naples 27
Hyderabad 26
Suffern 26
Guangzhou 25
Montreal 25
Lawrenceville 24
Tianjin 24
Amsterdam 23
Shanghai 23
Turin 23
Vienna 23
Johannesburg 21
San Francisco 19
Toronto 19
Philadelphia 18
San José 18
Dhaka 17
Kingston 17
Randolph Township 17
Brasília 16
Denver 16
Nuremberg 16
Porto Alegre 16
Manchester 15
Seattle 15
Tashkent 15
Tokyo 15
Chennai 14
Guayaquil 14
Las Vegas 13
London 13
Warsaw 13
Washington 13
Quito 12
Caxias do Sul 11
Chandler 11
Charlotte 11
Cincinnati 11
Curitiba 11
Kuala Lumpur 11
Queens 11
Shenzhen 11
Ribeirão Preto 10
Amman 9
Baghdad 9
Boston 9
Campinas 9
Haiphong 9
Helsinki 9
Medellín 9
Springfield 9
Stockholm 9
Abidjan 8
Ankara 8
Baku 8
City of London 8
Cleveland 8
Franca 8
Lahore 8
Managua 8
Palermo 8
Prineville 8
Totale 6.843
Nome #
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation 302
The Inconclusive Results of the Studies on Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease: An Area of Darkness 260
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 181
Immature platelet fraction and the extent of coronary artery disease: a single centre study 162
Analysis of beta 1 and beta 2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 161
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 151
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 147
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 141
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study 126
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 121
A meta-analytic overview of thrombectomy during primary angioplasty 120
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 116
Antiplatelet Strategies for Older Patients with Acute Coronary Syndromes: Finding Directions in a Low-Evidence Field 112
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 112
Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study 111
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 107
Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial) 102
Impact of Diabetes on Long-Term Outcome After Primary Angioplasty: Insights from the DESERT cooperation 102
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI 101
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials 100
Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention 100
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis 100
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy 98
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry 98
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 97
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization 97
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 97
ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials 97
Diabetes, glucose control and mean platelet volume: a single-centre cohort study 96
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors 95
Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease 95
Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention 95
The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials 94
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 94
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry 93
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI 93
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease' 92
Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation) 90
Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty 90
Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty 89
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials 89
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 89
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 89
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial 88
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 88
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial 88
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention 87
Immature platelet fraction and the extent of coronary artery disease: A single centre study 87
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 86
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 86
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention 86
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 86
Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 85
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor 85
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience 85
Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation 85
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 85
Switching from clopidogrel to prasugrel in patients having coronary stent implantation 85
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient- level meta-analysis of randomized trials 85
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 84
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 84
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 83
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study 83
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 83
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 83
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies 83
Time-related changes in neointimal tissue coverage of a novel Sirolimus eluting stent: Serial observations with optical coherence tomography 83
Platelet GP IIb-IIIa receptor antagonists in primary angioplasty: Back to the future 82
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers 82
Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial) 82
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials 81
Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials 80
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 80
"Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia" 80
An unusual case of ECG ST-segment elevation 79
Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience 79
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 79
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 79
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 78
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 78
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 78
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty 77
Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 77
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 76
Adjunctive antithrombotic therapy during Primary PCI 75
Everolimus-eluting stent versus Sirolimus-eluting stent for prognostic significance 75
Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy 74
Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials 74
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 74
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study 73
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 73
Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography 72
Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials 71
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 71
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 71
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: the transcatheter valve and vessels trial (TCW trial): design and rationale 70
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 70
Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty 69
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention 69
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 68
Totale 9.541
Categoria #
all - tutte 58.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 0 1 2 1 0 1 3 1 3
2022/2023708 2 3 1 4 4 5 3 4 11 473 198 0
2023/2024389 2 31 68 22 26 34 38 4 1 34 8 121
2024/20252.566 21 27 28 176 142 106 90 338 621 152 321 544
2025/20266.999 310 478 454 327 493 1.269 977 770 786 416 370 349
2026/20273.285 589 590 866 1.240 0 0 0 0 0 0 0 0
Totale 13.975